Kratom Products Contain Dangerous Heavy Metals, FDA Warns

New research by federal health officials indicates that many kratom products contain high levels of metal elements, such as lead and nickel, which are dangerous for human consumption and could result in adverse health consequences. 

The FDA released a kratom advisory earlier this week, after researchers discovered the chemical makeup of the supplements may contain metals in doses that could result in human health risks, among other potential health issues that have been previously confirmed.

Kratom is a plant native to Asia, whose leaves are taken and crushed to be made into tea, or taken orally as an herbal supplement. Although the supplement is loosely regulated by the FDA, the U.S. Centers for Disease Control and Prevention (CDC) has found the herb has become increasingly popular across the United States over recent years.

Learn More About

Lead Poisoning Lawsuits

Children diagnosed with lead poisoning after exposure to peeling or chipping lead paint in a rental home may be entitled to financial compensation and benefits.

Learn More About this Lawsuit SEE IF YOU QUALIFY FOR COMPENSATION

In response to a multistate kratom salmonella outbreak earlier this year, FDA field officers collected 26 separate kratom products to undergo testing. During the analysis researchers discovered heavy metals such as lead and nickel at levels far exceeding what is considered safe for human consumption.

Although a single dose of the kratom was not deemed an imminent health risk, chronic and long-term use could result in consumers suffering from metal poisoning which may cause abdominal pains, nausea, vomiting, diarrhea, dehydration, heart abnormalities and a breakdown of the body’s nervous system.

The FDA warns that very little is known about the potential side effects of kratom, and that the herbal supplement has not been approved for medical purposes.

Previous studies have shown the herbal supplement may not be safe for medicinal uses, indicating that the chemical compounds of the supplement are similar to opioid painkillers, which are highly addictive and often abused. One study found 22 of the 25 compounds in kratom products were found to bind to mu-opioid receptors, making the supplement’s compounds similar to opioid properties and highly addictive.

Earlier this year in February, the FDA released a kratom warning, citing new research that indicated the herbal supplement has been linked to dozens of deaths. The FDA is aware of at least 44 deaths associated with the use of kratom products through its Adverse Event Reporting System, and has stated there is a vital need for additional regulation of the product.

Despite known health risks, kratom products are still heavily used across the nation with an estimated 5 million consumers using the products regularly, according to the American Kratom Association. However, some states have banned the sale and use of kratom products completely, including Alabama, Arkansas, Indiana, Tennessee, Vermont, Wisconsin, and the District of Columbia, Denver, and the cities of San Diego, California and Sarasota, Florida.

In 2016, the U.S. Justice Department’s Drug Enforcement Administration (DEA) proposed a rule in the Federal Register to temporarily list kratom as a Schedule I controlled substance, along with heroin and other highly addictive and dangerous drugs. The proposed rule was declined by Congress, forcing the DEA to withdraw its plan and call on the FDA to perform a scientific review of kratom.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Leadership Development Committee for Suboxone Dental Injury Lawyers Established in Federal MDL
Leadership Development Committee for Suboxone Dental Injury Lawyers Established in Federal MDL (Posted yesterday)

The U.S. District Judge presiding over all Suboxone lawsuits has created a mentorship program to use the litigation to provide some attorneys an opportunity to gain experience in handling complex federal multidistrict litigations.

Gilead Settlement Resolves 2,625 HIV Drug Lawsuits Pending in Federal Courts for $40M
Gilead Settlement Resolves 2,625 HIV Drug Lawsuits Pending in Federal Courts for $40M (Posted 3 days ago)

Gilead says it will pay $40 million to resolve HIV drug lawsuits over Truvada, Atripla, Viread, Stribild and Complera pending in the federal court system, involving claims that the the company sat on safer formulations of the drugs for years to increase profits.